With a valuation of <b>$350 million</b> in 2023, the <b>Methylcobalamin(Mecobalamin) Market</b> is expected to reach <b>$650 million </b> by 2033, growing at a CAGR of <b>6.8%</b> from 2024 onwards. The report encompasses various segments and analyzes the trends and factors significantly impacting the market.
